Stockholders' Equity - Narrative (Details) - USD ($)				9 Months Ended	16 Months Ended	105 Months Ended
	Jun. 03, 2024	Jun. 30, 2015	Nov. 14, 2013	Sep. 30, 2024	Sep. 30, 2024	Sep. 30, 2024	Jun. 05, 2023
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)				0
Exercises in period, intrinsic value				$ 22,174,000
Compensation cost not yet recognized, non-option				0	$ 0	$ 0
Restricted Stock Units and Performance Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation cost not yet recognized, non-option				$ 198,011,000	$ 198,011,000	$ 198,011,000
Compensation cost not yet recognized, period for recognition				2 years 3 months 3 days
The 2013 Omnibus Equity Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)			5,713,899
Capital shares reserved for future issuance, annual increase, maximum (in shares)				27,579,672	27,579,672	27,579,672
Vesting period (in years)			4 years
Granted (in shares)					0
Shares available for grant (in shares)				0	0	0
Polyrize Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for grant (in shares)				0	0	0
2023 Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)							5,500,000
Number of additional shares authorized (in shares)	4,400,000
2015 ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of shares authorized (in shares)		1,500,000
Number of additional shares authorized (in shares)						3,908,910
Maximum employee subscription rate		15.00%
Purchase price of common stock, percent		85.00%
Percent of shares increase, employee stock purchase plan		1.00%
Common stock availability threshold, employee stock purchase plan		2.00%
Shares increase threshold, employee stock purchase plan (in shares)		1,200,000